The new UroLift ATC® Advanced Tissue Control System delivers the same, proven implant through an enhanced delivery device tip that enables urologists to more easily treat BPH patients with challenging anatomies, including an obstructive median lobe and large lateral lobes. The wings are designed to provide more tissue control which may reduce procedural manipulations.
Tissue Control Wings
Needle Location Marker
Atraumatic Design
Wings hold tissue, providing enhanced control during the procedure
*The Clinical Results page features studies based on the previous generation UroLift System (UL400)
Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and can include discomfort when urinating, urgency, inability to control the urge, pelvic pain, and some blood in the urine.1 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Learn More
Consult the Instructions for Use (IFU) for more information.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
Source Information
+ Dr. Steven Gange is a paid consultant for NeoTract | Teleflex Interventional Urology
1. Roehrborn, J Urol 2013
4155 Hopyard Road
Pleasanton, CA 94588
Phone: (925) 401-0700
Fax: (925) 401-0699
© 2023 Teleflex Incorporated. All rights reserved. MAC02126-02 Rev A | Terms of Use | Privacy Policy | Patient Safety